© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Three experts discuss advanced non-small cell lung cancer and what it means to have a treat a KRAS G12C mutation.
June 22nd 2022
Joshua Sabari, MD, provides a breakdown of advanced non-small cell lung cancer (NSCLC) and its actionable mutations.
Three medical experts highlight unmet needs they routinely run into while treating patients with NSCLC.
June 28th 2022
Alexander Spira, MD, PhD, FACP provides an overview of molecular testing in NSCLC.
Two medical oncologists break down the role molecular testing has when treating NSCLC, from guidelines to common methods to barriers.